Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Cited by (1,001)

Items 401–500 of 1,001

1. Osteosarcoma in Pediatric Patients and Young Adults: A Single Institution Retrospective Review of Presentation, Therapy, and Outcome
   Candace L. Haddox, Gang Han, Leon Anijar, Odion T. Binitie, George Douglas Letson, Marilyn M. Bui, Damon R. Reed · 2014 · Sarcoma
2. Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors
   Neelam Wadhwa · 2014 · Indian Journal of Orthopaedics
3. Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?
   Norio Yamamoto, Hiroyuki Tsuchiya · 2013 · Expert Opinion on Pharmacotherapy
4. Progress and Opportunities for Immune Therapeutics in Osteosarcoma
   Christina K. Lettieri, Nicole Appel, Nicole Labban, Danielle M. Lussier, Joseph N. Blattman, Pooja Hingorani · 2016 · Immunotherapy
5. Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base
   Benjamin James Miller, Yubo Gao, Kyle R. Duchman · 2017 · Cancer Epidemiology
6. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen ‘OGS-12’
   Jyoti Bajpai, Arun Chandrasekharan, Vikas T. Talreja, Vijai Simha, M V Chandrakanth, Bharat Rekhi, Sachin Khurana, Arif Salam Khan, Tushar Shailesh Vora, Jaya Ghosh et al. · 2017 · European Journal of Cancer
7. mi RNA profiling identifies deregulated mi RNA s associated with osteosarcoma development and time to metastasis in two large cohorts
   Gitte Brinch Andersen, Alice Knudsen, Henrik Hager, Lise Lotte Hansen, Jörg Tost · 2017 · Molecular Oncology
8. Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells
   Jahnabi Roy, Payam Dibaeinia, Timothy M. Fan, Saurabh Sinha, Aditi Das · 2018 · Journal of Lipid Research
9. Adjuvant Biophysical Therapies in Osteosarcoma
   Valeria Carina, Viviana Costa, Maria Sartori, Daniele Bellavia, Angela De Luca, Lavinia Raimondi, Milena Fini, Gianluca Giavaresi · 2019 · Cancers
10. Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy
    Jianfang Niu, Taiqiang Yan, Wei Guo, Wei Ting Wang, Zhi‐Qing Zhao, Tingting Ren, Yi Huang, Hongliang Zhang, Yiyang Yu, Xin Liang · 2020 · Frontiers in Oncology
11. Total Femur Replacement Procedures in Tumor Treatment
    Henry J. Mankin, Francis John Hornicek, Michael Harris · 2005 · Clinical Orthopaedics and Related Research
12. T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
    Wang, Zhan, Li, Binghao, Ren, Yingqing, Ye, Zhaoming · 2016 · Frontiers in Immunology
13. Initial Symptoms and Delayed Diagnosis of Osteosarcoma around the Knee Joint
    Kok Long Pan, Wai Hoong Chan, Yin Yin Chia · 2010 · Journal of orthopaedic surgery
14. Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre‐chemotherapeutic osteosarcoma cell line (OS1)
    Barry Peter Pereira, Yefang Zhou, Anurag Gupta, David Tai Leong, Khin Zarchi Aung, Ling Ling, Robert W. H. Pho, Mario A. Galindo, Manuel Salto‐Tellez, Gary S. Stein et al. · 2009 · Journal of Cellular Physiology
15. Cyclooxygenase-2 Overexpression Predicts Poor Survival in Patients with High-grade Extremity Osteosarcoma: A Pilot Study
    Hiroshi Urakawa, Yoshihiro Nishida, Takahiro Naruse, Hiroatsu Nakashima, Naoki Ishiguro · 2009 · Clinical Orthopaedics and Related Research
16. Histopathologic Features of Prognostic Significance in High-Grade Osteosarcoma
    Michael Herman Chui, Rita A. Kandel, Marcus Wong, Anthony Michael Griffin, Robert Stuart Bell, Martin E. Blackstein, Jay Steven Wunder, Brendan Craig Dickson · 2016 · Archives of Pathology & Laboratory Medicine
17. Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway
    Jianwei Zhu, Yang Sun, Ying Lü, Xiubo Jiang, Bo Ma, Lisha Yu, Jie Zhang, Xiaochen Dong, Qi Zhang · 2018 · Cell Death and Disease
18. Pediatric Sarcomas
    Regan Frances Williams, Israel Fernández‐Pineda, Ankush Gosain · 2016 · Surgical Clinics of North America
19. Tumor Necrosis Rate Adjusted by Tumor Volume Change Is a Better Predictor of Survival of Localized Osteosarcoma Patients
    Min Suk Kim, Soo‐Yong Lee, Wan Hyeong Cho, Won Seok Song, Jae‐Soo Koh, Jun Ah Lee, Ji Young Yoo, Dae‐Geun Jeon · 2007 · Annals of Surgical Oncology
20. Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma
    Dan Fei, Xiaona Zhang, Jinxiang Liu, Long Tan, Jie Xing, Dongxu Zhao, Yang Zhang · 2018 · Cellular Physiology and Biochemistry · Retracted
21. Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?
    Caleb Kim, Lara Emily Davis, Catherine Michelle Albert, Brian L. Samuels, Jesse L. Roberts, Michael J. Wagner · 2023 · Cancers
22. Multiplanar Osteotomy with Limited Wide Margins: A Tissue Preserving Surgical Technique for High-grade Bone Sarcomas
    Raffi S. Avedian, Rex C. Haydon, Terrance D. Peabody · 2010 · Clinical Orthopaedics and Related Research
23. Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi‐specific monoclonal antibody MsMab‐1
    Xing Liu, Yukinari Kato, Mika Kato Kaneko, Masato Sugawara, Satoshi Ogasawara, Yuta Tsujimoto, Yasushi Naganuma, Mitsunori Yamakawa, Takashi Tsuchiya, Michiaki Takagi · 2013 · Cancer Medicine
24. Cancer‐testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis
    Changye Zou, Jingnan Shen, Qinglian Tang, Yang Zheng, Junqiang Yin, Zhibin Li, Xianbiao Xie, Gang Huang, Dina Chelouche Lev, Jin Wang · 2011 · Cancer
25. Management of infection following reconstruction in bone tumors
    Sudhir K. Kapoor, Rajesh Thiyam · 2015 · Journal of Clinical Orthopaedics and Trauma
26. Prognostic Factors in the Survival of Patients Diagnosed with Primary Non-Metastatic Osteosarcoma with a Poor Response to Neoadjuvant Chemotherapy
    Rosalvo Zósimo Bispo Júnior, Olavo Pires de Camargo · 2009 · Clinics
27. The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma
    Y-H. Zhang, B. Li, Lisong Shen, Y. Shen, Xiao‐Dong Chen · 2013 · International Journal of Immunopathology and Pharmacology
28. Defective autophagy leads to the suppression of stem-like features of CD271+ osteosarcoma cells
    Dong Zhang, Qing Zhao, Hao Sun, Lijuan Yin, Jiajun Wu, Jun Xu, Tianxiang He, Chunlei Yang, Chengwei Liang · 2016 · Journal of Biomedical Science
29. Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells
    Yuan Gao, Benyuan Zhang, Yuming Wang, Guanning Shang · 2018 · Oncology Reports
30. Identification of Prognostic and Predictive Osteosarcoma Biomarkers
    Radoslav Zamborský, Milan Kokavec, Štefan Harsányi, Ľuboš Danišovič · 2019 · Medical Sciences
31. Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study
    Chao Zhang, Xu Guo, Yao Xu, Xiuxin Han, Jun Cai, Xin Wang, Guowen Wang · 2019 · Sao Paulo Medical Journal
32. Prediction of Chemotherapy Response by PET-CT in Osteosarcoma
    Jyoti Bajpai, Rakesh Kumar, Vishnubhatla Sreenivas, Mehar Chand Sharma, Shah Alam Khan, Shishir Rastogi, Arun Malhotra, Shivanand Gamnagatti, Rajender Kumar, Rajni Safaya et al. · 2011 · Journal of Pediatric Hematology/Oncology
33. Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy
    Dian Wang, Jonathan Harris, William G Kraybill, Burton Larry Eisenberg, David G. Kirsch, David S. Ettinger, John Michael Kane, Parul Nafees Barry, A.O. Naghavi, Carolyn R Freeman et al. · 2023 · JAMA Oncology
34. Establishment of a patient-derived orthotopic osteosarcoma mouse model
    Claudia Blattmann, Markus Thiemann, Albrecht Stenzinger, Eva K. Roth, Anne Dittmar, Hendrik Witt, Burkhard Lehner, Eva Kristin Renker, Manfred Jugold, Viktoria Eichwald et al. · 2015 · Journal of Translational Medicine
35. Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells
    Xiaodong Mu, Christian E. Isaac, Trevor Schott, Johnny Huard, Kurt Richard Weiss · 2013 · Sarcoma
36. The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone
    Tomoki Nakamura, Robert John Grimer, Czar Louie Gaston, Munenori Watanuki, Akihiro Sudo, Lee Marcus Jeys · 2013 · The Bone & Joint Journal
37. Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome
    Phillip A. Letourneau, Lianchun Xiao, Matthew T. Harting, Kevin P. Lally, Charles S. Cox, Richard J. Andrassy, Andrea Anita Hayes-Jordan · 2011 · Journal of Pediatric Surgery
38. Delay in Diagnosis and Its Effect on Clinical Outcome in High‐grade Sarcoma of Bone: A Referral Oncological Centre Study
    Louren M. Goedhart, Jasper G Gerbers, Joris J. W. Ploegmakers, Paul C. Jutte · 2016 · Orthopaedic Surgery
39. Long non‐coding PANDAR as a novel biomarker in human cancer: A systematic review
    Yifan Zou, Yuantang Zhong, Jun‐Jie Wu, Huizhong Xiao, Xintao Zhang, Xinhui Liao, Jianfa Li, Xuhua Mao, Yuchen Liu, Fuyou Zhang · 2017 · Cell Proliferation
40. The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis
    Francisco Villanueva, Hector Araya, Pedro Briceño, Nelson Varela, Andres Stevenson, Sofía Jerez, Fabián Tempio, Jonás Chnaiderman, Carola Perez, Milena Villarroel C. et al. · 2019 · Journal of Cellular Physiology
41. Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcoma
    Jos A. M. Bramer, Adesegun A. Abudu, Roger M. Tillman, S. R. Carter, Vaiyapuri P. Sumathi, Robert John Grimer · 2005 · European Journal of Cancer
42. The Scandinavian Sarcoma Group experience
    Sigbjørn Smeland, Thomas Wiebe, Otte Brosjö, Tom Böhling, Thor A Alvegård, Ssg Ix · 2004
43. Genomics and the Immune Landscape of Osteosarcoma
    Wu, Chia-Chin, Livingston, J. Andrew · 2020 · Advances in Experimental Medicine and Biology
44. Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma
    Mika Kato Kaneko, Hiroharu Oki, Satoshi Ogasawara, Michiaki Takagi, Yukinari Kato · 2015 · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
45. Honeycomb-Like Hydrogel Microspheres for 3D Bulk Construction of Tumor Models
    Jiachen He, Chichi Chen, Liang Chen, Ruoyu Cheng, Jie Sun, Xingzhi Liu, Lin Wang, Can Zhu, Sihan Hu, Yuan Xue et al. · 2022 · Research
46. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma
    Winnie W. Lo, Jay Steven Wunder, Brendan Craig Dickson, Veronica T. Campbell, Karen McGovern, Benjamin Aaron Alman, Irene Louise Andrulis · 2013 · Cancer
47. The Influence of the Alloy of Megaprostheses on Infection Rate
    Georg Gosheger, Christian Goetze, Jendrik Hardes, U. Joosten, Winfried Winkelmann, Christof von Eiff · 2008 · The Journal of Arthroplasty
48. Cryoimmunology for malignant bone and soft-tissue tumors
    Hideji Nishida, Norio Yamamoto, Yoshikazu Tanzawa, Hiroyuki Tsuchiya · 2011 · International Journal of Clinical Oncology
49. Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
    AM McTiernan, Rachel C. Jinks, Matthew Robert Sydes, Barbara Uscinska, Jane Hook, Martine M. Van Glabbeke, Vivien H. C. Bramwell, Ian J. Lewis, Antonïe H.M. Taminiau, Marianne A. Nooij et al. · 2011 · European Journal of Cancer
50. Current questions in bone sarcomas
    Sandra J. Strauss, Jeremy Whelan · 2018 · Current Opinion in Oncology
51. Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
    Chunfeng Xu, Mingjie Wang, Wei Guo, Wei Yan Sun, Yuelian Liu · 2021 · Frontiers in Oncology
52. A facile strategy toward hierarchically porous composite scaffold for osteosarcoma ablation and massive bone defect repair
    Tingxian Ling, Xiang‐Jun Zha, Kai Zhou, Xing Zhao, Jin Feng Jia, Kaiqi Pan, Anjing Chen, Wei Min Yang, Zongke Zhou · 2022 · Composites Part B Engineering
53. RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology
    Kosei Ando, Kanji Mori, Françoise Rédiní, Dominique Heymann · 2008 · Current Drug Discovery Technologies
54. Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.
    Sara Del Mare, Kyle C. Kurek, Gary S. Stein, Jane B. Lian, Rami I. Aqeilan · 2011 · Europe PMC (PubMed Central)
55. Natural killer cell therapy and aerosol interleukin‐2 for the treatment of osteosarcoma lung metastasis
    Sergei R. Guma, Dean Anthony Lee, Ling Yu, Nancy Beatriz Gordon, Dennis P.M. Hughes, John Stewart, Wei Wang, Eugenie S. Kleinerman · 2013 · Pediatric Blood & Cancer
56. Osteosarcoma in the elderly over 60 years: A multicenter study by the Japanese musculoskeletal oncology group
    Yoshihiro Nishida, Kazuo Isu, Takafumi Ueda, Yutaka Nishimoto, Hiroyuki Tsuchiya, Takuro Wada, Keiji Sato, Satoshi Tsukushi, Hideshi Sugiura · 2009 · Journal of Surgical Oncology
57. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma
    Daisuke Kubota, Kenta Mukaihara, Akihiko Yoshida, Hitoshi Tsuda, Akira Kawai, Tadashi Kondo · 2013 · Journal of Proteomics
58. Prognostic nomograms for predicting overall and cancer-specific survival of high-grade osteosarcoma patients
    Kehan Song, Jian Song, Feiyan Chen, Kai‐Yuan Lin, Xiaosheng Ma, Jianyuan Jiang · 2018 · Journal of bone oncology
59. Surgical options and reconstruction strategies for primary bone tumors of distal tibia: A systematic review of complications and functional outcome
    Zhiqing Zhao, Taiqiang Yan, Wei Guo, Rongli Yang, Xiaodong Tang, Wei Wang · 2018 · Journal of bone oncology
60. Delaying surgery with chemotherapy for osteosarcoma of the extremities
    Stefan Bielack, Jan-Nicolas Machatschek, Silke Flege, Heribert Jürgens · 2004 · Expert Opinion on Pharmacotherapy
61. Specific Tyrosine Kinase Inhibitors Regulate Human Osteosarcoma Cells In vitro
    Patrick J. Messerschmitt, Ashley N. Rettew, Robert E. Brookover, Ryan Garcia, Patrick J. Getty, Edward M. Greenfield · 2008 · Clinical Orthopaedics and Related Research
62. VEGF and BMP Expression in Mouse Osteosarcoma Cells
    Kurt Richard Weiss, Gregory M Cooper, Julie A. Jadlowiec, Richard L. McGough, Johnny Huard · 2006 · Clinical Orthopaedics and Related Research
63. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan
    Ikuo Kudawara, Yasuaki Aoki, Takafumi Ueda, Nobuhito Araki, Norifumi Naka, Hirofumi Nakanishi, Akihiko Matsumine, Makoto Ieguchi, Shigeki Mori, Akira Myoui et al. · 2013 · Journal of Chemotherapy
64. TUMOR ANGIOGENESIS AND OUTCOME IN OSTEOSARCOMA
    Danko Mikulić, Ivana Ilić, Mladen Ćepulić, Dubravko Orlić, Jasminka Stepan Giljević, Ivan Fattorini, Sven Seiwerth · 2004 · Pediatric Hematology and Oncology
65. Prognostic Factors and Treatment Results of High-Grade Osteosarcoma in Norway: A Scope Beyond the “Classical” Patient
    Kjetil Berner, Kirsten Sundby Hall, Odd R. Monge, Harald Weedon‐Fekjær, Olga Zaikova, Øyvind Sverre Bruland · 2015 · Sarcoma
66. 18F-FDG PET-CT in paediatric oncology: established and emerging applications
    Greg Chambers, Russell Thomas Frood, Chirag Patel, Andrew Frederick Scarsbrook · 2018 · British Journal of Radiology
67. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma
    Qiankun Yang, Tong Chen, Zhongxiang Yao, Xiaojing Zhang · 2020 · World Journal of Surgical Oncology
68. Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft‐tissue sarcoma
    Michael J. Absalon, M. Beth McCarville, Tiebin Liu, Victor M. Santana, Najat C. Daw, Fariba Navid · 2008 · Pediatric Blood & Cancer
69. Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling
    Lingfeng Yu, Hao Zhu, Zhen Wang, Jianhao Huang, Yan Zhu, Gentao Fan, Yicun Wang, Xi Chen, Guangxin Zhou · 2022 · Molecular Cancer
70. Critical Role of Heat Shock Protein 27 in Bufalin-Induced Apoptosis in Human Osteosarcomas: A Proteomic-Based Research
    Xian-Biao Xie, Jun-qiang Yin, Li-Li Wen, Zhen-hua Gao, Chang-Ye Zou, Jin Wang, Gang Huang, Qing-Lian Tang, Chiara Colombo, Wei-ling He et al. · 2012 · PLoS ONE
71. Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate
    Shakila Jabeen, Laila Holmboe, Grethe I.G. Alnæs, Anders Andersen, Kirsten Sundby Hall, Vessela Nedelcheva Kristensen · 2015 · The Pharmacogenomics Journal
72. A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment
    Melanie M. Hagleitner, Marieke J. H. Coenen, Hans A. J. Gelderblom, Remco R. Makkinje, Hanneke I. Vos, Eveline S.J.M. de Bont, Winette T.A. van der Graaf, Hendrik W. B. Schreuder, Uta E. Flucke, Frank N. van Leeuwen et al. · 2015 · Clinical Cancer Research
73. Clinico-histologic parameters of osteosarcoma patients with late relapse
    Esther I. Hauben, Stefan Bielack, Robert John Grimer, Gernot Jundt, Peter Reichardt, Matthew Robert Sydes, A. H. M. Taminiau, Pancras C.W. Hogendoorn · 2006 · European Journal of Cancer
74. Infarct-associated Bone Sarcomas
    Gregory F. Domson, Amir H. Shahlaee, John David Reith, Charles H. Bush, C. Parker Gibbs · 2009 · Clinical Orthopaedics and Related Research
75. Re-implantation of tumour tissue treated by cryotreatment with liquid nitrogen induces anti-tumour activity against murine osteosarcoma
    H. Nishida, Hiroyuki Tsuchiya, K. Tomita · 2008 · Journal of Bone and Joint Surgery - British Volume
76. Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis
    Ling Ren, Ellen S. Hong, Arnulfo Mendoza, Sameer H. Issaq, Christine Tran Hoang, Michael M. Lizardo, Amy Kathleen LeBlanc, Chand Khanna · 2017 · Oncotarget
77. Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2
    Cristina Meazza, Graziella Cefalo, Maura Massimino, Primo Andrea Daolio, Ugo Pastorino, Paolo Scanagatta, Carlo Morosi, Marta Giorgia Podda, Andrea Ferrari, Monica Terenziani et al. · 2017 · Medical Oncology
78. An NIR triphenylamine grafted BODIPY derivative with high photothermal conversion efficiency and singlet oxygen generation for imaging guided phototherapy
    Jianwei Zhu, Jianhua Zou, Zhanjie Zhang, Jie Zhang, Yang Sun, Xiaochen Dong, Qi Zhang · 2019 · Materials Chemistry Frontiers
79. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell–like Properties in Osteosarcoma
    Bing Lu, Yangyang He, Jincan He, Li Wang, Zhenguo Liu, Jiayan Yang, Zhuoxing Gao, Guohao Lu, Changye Zou, Wei Zhao · 2019 · Molecular Cancer Research
80. Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination
    Tine Greve, Vera Timmermans Wielenga, Morten Grauslund, Nils Sørensen, Dorte Bang Christiansen, Mikkel Rosendahl, Claus Yding Andersen · 2013 · European Journal of Cancer
81. ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide
    Bo Jiang, Yan Li-jun, Qian Wu · 2019 · DNA and Cell Biology
82. Adverse impact of regional lymph node involvement in osteosarcoma
    Sheila Thampi, Katherine K. Matthay, Robert E. Goldsby, Steven G. DuBois · 2013 · European Journal of Cancer
83. Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma
    Katja Goričar, Viljem Kovač, Janez Jazbec, Branko Zakotnik, Janez Lamovec, Vita Dolžan · 2015 · Cancer Epidemiology
84. MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1
    Dongdong Cheng, Tao Yu, Tu Hu, Ming Yao, Cun-yi Fan, Qingcheng Yang · 2015 · Oncotarget
85. Association of MMP-2 expression and prognosis in osteosarcoma patients.
    Miao Zhang, Xuran Zhang · 2015 · PubMed Central
86. Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma
    Ferdinand Wagner, Boris Michael Holzapfel, Jacqui McGovern, Alimohammad Shafiee, Jeremy Baldwin, Laure C. Martine, Christoph A. Lahr, Felix M. Wunner, Thor Friis, Onur Bas et al. · 2018 · Biomaterials
87. MRI Identification of the Osseous Extent of Pediatric Bone Sarcomas
    Matthew J. Thompson, John C. Shapton, Stephanie E. W. Punt, Christopher N. Johnson, Ernest U. Conrad · 2018 · Clinical Orthopaedics and Related Research
88. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes
    Wangmi Liu, Xiankuan Xie, Yiying Qi, Jiayan Wu · 2021 · JAMA Network Open
89. Osteosarcomas after the Age of 50: A Clinicopathologic Study of 64 Cases?an Experience in Northern Japan
    Kyoji Okada, Tadashi Hasegawa, Jun Nishida, Akira Ogose, Takahiro Tajino, Toshihisa Osanai, Michiro Yanagisawa, Masahito Hatori · 2004 · Annals of Surgical Oncology
90. Central Nervous System Involvement in Children with Sarcoma
    Sergey Postovsky, Shifra Ash, I.N. Ramu, Y. Yaniv, Rina Zaizov, Boris Futerman, Ronit Elhasid, A. Ben Barak, A. Halil, Miriam Weyl Ben Arush · 2003 · Oncology
91. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach
    Courtney R. Schott, Amanda L. Koehne, Leanne C. Sayles, Elizabeth P. Young, Cuyler Luck, Katharine Yu, Alex Gia Lee, Marcus R. Breese, Stanley G. Leung, Hang Xu et al. · 2023 · Clinical Cancer Research
92. Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: A systemic review and meta‐analysis of cohort studies
    Lingling Sun, Yingiun Li, Jian Zhang, Hengyuan Li, Binghao Li, Zhaoming Ye · 2014 · Journal of Orthopaedic Research®
93. Molecular pathogenesis and therapeutic strategies of human osteosarcoma
    Sahitya K. Denduluri, Zhongliang Wang, Zhengjian Yan, Jing Wang, Qiang Wei, Maryam K. Mohammed, Rex C. Haydon, Hue H. Luu, Tong‐Chuan He · 2016 · Journal of Biomedical Research
94. Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma
    Daniel Baumhoer, Jan Smida, Stephanie Zillmer, Michael Rosemann, Michael John Atkinson, Peter Jon Nelson, Gernot Jundt, Irene von Luettichau, Michaela Nathrath · 2011 · Modern Pathology
95. Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
    Zuzanna Baranski, Yvonne de Jong, Trayana Ilkova, Elisabeth F.P. Peterse, Anne‐Marie Cleton-Jansen, Bob van de Water, Pancras C.W. Hogendoorn, Judith V.M.G. Bovée, Erik H.J. Danen · 2015 · Oncotarget
96. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway
    Kyung‐Ran Park, Hyung‐Mun Yun, Tran-Hong Quang, Hyuncheol Oh, Dong‐Sung Lee, Q‐Schick Auh, Eun-Cheol Kim · 2016 · Oncotarget
97. Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K/Akt pathway
    Hongliang Wang, NA SUN, Xin Li, Ka Li, Jiguang Tian, Jianmin Li · 2016 · Oncology Reports
98. Local Control of Soft Tissue and Bone Sarcomas
    Joseph Garfield Crompton, Koichi Ogura, Nicholas Matthew Bernthal, Akira Kawai, Fritz C. Eilber · 2017 · Journal of Clinical Oncology
99. Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study
    Hyung‐Jun Im, Yi Zhang, Huiyun Wu, Jianrong Wu, Najat C. Daw, Fariba Navid, Barry Lynn Shulkin, Steve Y. Cho · 2018 · Radiology
100. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma
     Yunxing Zhang, Meng Wang, Hongxia Cui · 2018 · Biomedicine & Pharmacotherapy